BEUDAMED
    15 results · 26ms · Sources: EU EUDAMED, US FDA

    Get notified when this changes

    We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.
    Filters Regulation: Us FDA ×

    Medline ReNewal Reprocessed Endopath Endoscopic Instruments

    FDA 510(k)
    FDA Class 2 ·General, Plastic Surgery

    2.0 LACTOSORB SYSTEM

    FDA UDI
    BIOMET MICROFIXATION, INC·00841036055165·

    PATRIOT TRANSCONTINENTAL M SPACERS

    FDA 510(k)
    FDA Class 2 ·Orthopedic

    STIMUPLEX HNS-12, MODEL 4892098

    FDA 510(k)
    FDA Class 2 ·Anesthesiology

    UNKNOWN GAMMA3 LONG NAIL

    FDA Adverse Event
    Injury ·STRYKER TRAUMA KIEL·Product code HSB·March 9, 2021

    PULSE-GENERATOR, DUAL CHAMBER, IMPLANTABLE

    FDA Adverse Event
    Malfunction ·MEDTRONIC MILACA, INC.·Product code LWP·June 7, 2013

    ANGIOSCULPT PTA SCORING BALLOON CATHETER (OTW)

    FDA Adverse Event
    Malfunction ·ANGIOSCORE, INC.·Product code LIT·October 3, 2014

    INTERSTIM

    FDA Adverse Event
    Malfunction ·MEDTRONIC NEUROMODULATION·Product code EZW·June 23, 2011

    UNKNOWN GAMMA3 SHORT NAIL

    FDA Adverse Event
    Injury ·STRYKER TRAUMA KIEL·Product code HSB·March 9, 2021

    UNKNOWN GAMMA3 LONG NAIL CASE 3

    FDA Adverse Event
    Injury ·STRYKER TRAUMA KIEL·Product code HSB·March 9, 2021

    UNKNOWN GAMMA3 LONG NAIL CASE 2

    FDA Adverse Event
    Injury ·STRYKER TRAUMA KIEL·Product code HSB·March 9, 2021

    UNKNOWN GAMMA3 LONG NAIL CASE 1

    FDA Adverse Event
    Injury ·STRYKER TRAUMA KIEL·Product code HSB·March 9, 2021

    TRUE METRIX AIR

    FDA Adverse Event
    Malfunction ·TRIVIDIA HEALTH INC·Product code NBW·June 23, 2025

    ELEKTA LIMITED Elekta Synergy, REF MRT 8501, MRT 8511; Medical Charged-Particle Radiation Therapy System Accelerator, Linear

    FDA Enforcement
    Class II ·Ongoing·Elekta, Inc.·December 13, 2023

    CADD-Solis VIP ambulatory Infusion Pumps, Model 2110. Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.

    FDA Enforcement
    Class I ·Ongoing·Smiths Medical ASD Inc.·August 14, 2024